Table 1. Pharmacokinetic parameters of compounds.
Compound | OB(%) | DL | BBB | HL | RBN |
---|---|---|---|---|---|
Rutin | 3.20 | 0.68 | -2.75 | - | 6 |
Matrine | 63.77 | 0.25 | 1.52 | 6.69 | 0 |
Melanin | 26.40 | 0.67 | -0.63 | - | 0 |
Luteolin | 36.16 | 0.25 | -0.84 | 15.94 | 1 |
Caffeine | 89.46 | 0.08 | -0.01 | 13.64 | 0 |
Aucubin | 4.17 | 0.33 | -2.90 | - | 4 |
Piperine | 42.52 | 0.23 | 0.62 | 10.25 | 3 |
Wogonin | 30.68 | 0.23 | 0.04 | 17.75 | 2 |
Daidzein | 19.44 | 0.19 | -0.22 | - | 1 |
Myricetin | 13.75 | 0.31 | -1.01 | - | 1 |
Quercetin | 46.43 | 0.28 | -0.77 | 14.40 | 1 |
Ursolic acid | 16.77 | 0.75 | 0.07 | - | 1 |
Resveratrol | 19.07 | 0.11 | -0.01 | - | 2 |
Paeoniflorin | 53.87 | 0.79 | -1.86 | 13.88 | 7 |
Sinomenine | 30.98 | 0.46 | 0.43 | 1.79 | 2 |
Atractylenolide I | 37.37 | 0.15 | 1.29 | 7.10 | 0 |
γ-aminobutyric acid | 24.09 | 0.01 | -0.57 | - | 3 |
Abbreviations: BBB, blood–brain barrier; DL, drug-likeness; HL, half-life; OB, oral bioavailability; RBN, rotatable bond number.